Target intelligence / Profile preview

Tumor-associated ligand of gamma delta T cell receptor

Molecular classification
Receptor ligand, Immune cell ligand, Stress-induced protein, Butyrophilin family member, MHC class I-related molecule, Co-stimulatory molecule
01

Overview

Tumor-associated ligands recognized by the gamma delta T cell receptor (γδTCR) are a diverse group of stress-induced molecules upregulated on tumor cells and infected or stressed cells. These include NKG2D ligands such as MICA, MICB, and ULBPs, butyrophilin family members like BTN3A1, and co-stimulatory ligands such as JAML. Recognition of these ligands by γδTCR—often together with engagement of activating co-receptors—triggers immune responses including cytotoxicity and cytokine production by γδ T lymphocytes, contributing to immune surveillance and antitumor immunity[5][7][9][1][4].

Other names
γδTCR ligandNKG2D ligandStress-induced ligandBTN3A1 ligandJAML ligandImmune stress ligand
02

Mechanism of action

Ligand recognition by γδTCR triggers activation and cytotoxicity of γδ T lymphocytes, leading to tumor cell killing[5][7][9]. Engagement of co-receptors such as NKG2D or BTN3A family enhances or modulates these responses[4][9].

03

Biological functions

Immune surveillanceActivation of γδ T lymphocytesSignal transductionInduction of cytokine productionPromotion of cell cytotoxicity
04

Disease associations

CancerInfectionInflammationImmune modulation
05

Safety considerations

Lack of specificity: broad engagement means potential for off-tumor cytotoxicityTumor immune evasion: downregulation of stress ligands can impair surveillance[9]Cytokine release or autoimmunity due to non-specific activation
06

Interacting drugs

Zoledronate (indirectly increases expression of target ligands on tumor cells)

2 more in the full profile.

07

Biomarkers

MICA, MICB, ULBP1–6 (NKG2D ligands)Butyrophilin 3A1 (BTN3A1) expression on tumor cellsJAML expression on TIL subsets[1][9]

Beyond the preview

Go deeper on Tumor-associated ligand of gamma delta T cell receptor.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tumor-associated ligand of gamma delta T cell receptor.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call